Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma

被引:256
作者
Kinnula, VL
Lehtonen, S
Sormunen, R
Kaarteenaho-Wiik, R
Kang, SW
Rhee, SG
Soini, Y
机构
[1] Univ Oulu, Dept Internal Med, Div Pulm, SF-90220 Oulu, Finland
[2] Oulu Univ Hosp, Oulu, Finland
[3] Bioctr Oulu, Oulu, Finland
[4] NIH, Lab Cell Signaling, Bethesda, MD 20892 USA
[5] Univ Oulu, Dept Pathol, SF-90220 Oulu, Finland
关键词
peroxiredoxin; mesothelioma; lung; antioxidant; radical; tumour;
D O I
10.1002/path.1042
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Peroxiredoxins (Prxs) are a recently characterized group of thiol-containing proteins with efficient antioxidant capacity, capable of consuming hydrogen peroxide in living cells. Altogether six distinct Prxs have been characterized in mammalian tissues. Their expression was investigated in histological samples of mesothelioma and in cell lines established from the tumours of mesothelioma patients. Four cases with histopathologically healthy pleura from non-smokers were used as controls. Healthy pleural mesothelium was negative or very weakly positive for all Prxs In mesothelioma, the most prominent reactivity was observed with Prxs I, II, V, and VI. Prx I was highly or moderately expressed in 25/36 cases, the corresponding figures for Prxs II-VI being 27/36 (Prx II), 13/36 (Prx III), 2/36 (Prx IV), 24/36 (Prx V), and 30/36 (Prx VI). Positive staining was observed both in the cytosolic and the nuclear compartment, with the exception of Prx III, which showed no nuclear reactivity. The staining pattern of Prxs III and V was granular. Immunoelectron microscopic localization of Prxs was in accordance with the immunohistochemical findings, showing diffuse cytoplasmic localization for Prxs I, II, IV, and VI and distinct mitochondrial labelling for Prxs III and V. There is-as no significant association between the extent of staining and different Prxs. It appeared that Prxs may not haw prognostic significance, but being prominently expressed in most mesotheliomas these proteins, at least in theory, may play a role in the primary drug resistance of this disease. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:316 / 323
页数:8
相关论文
共 34 条
[1]
Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin [J].
Chae, HZ ;
Kim, HJ ;
Kang, SW ;
Rhee, SG .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 45 (2-3) :101-112
[2]
ISHII T, 1993, J BIOL CHEM, V268, P18633
[3]
Antioxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells [J].
Järvinen, K ;
Pietarinen-Runtti, P ;
Linnainmaa, K ;
Raivio, KO ;
Krejsa, CM ;
Kavanagh, T ;
Kinnula, VL .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (04) :L696-L702
[4]
JARVINEN K, 1998, BRIT J CANCER, V77, P1097
[5]
Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation [J].
Jin, DY ;
Chae, HZ ;
Rhee, SG ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30952-30961
[6]
Generation of reactive oxygen species by human mesothelioma cells [J].
Kahlos, K ;
Pitkänen, S ;
Hassinen, I ;
Linnainmaa, K ;
Kinnula, V .
BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) :25-31
[7]
Kahlos K, 2001, CANCER, V91, P1349, DOI 10.1002/1097-0142(20010401)91:7<1349::AID-CNCR1138>3.0.CO
[8]
2-D
[9]
Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma [J].
Kahlos, K ;
Anttila, S ;
Asikainen, T ;
Kinnula, K ;
Raivio, KO ;
Mattson, K ;
Linnainmaa, K ;
Kinnula, VL .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 18 (04) :570-580
[10]
Characterization of a mammalian peroxiredoxin that contains one conserved cysteine [J].
Kang, SW ;
Baines, IC ;
Rhee, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (11) :6303-6311